Loading...
Loading...
Jefferies increases its price target from $5 to $8 on Hold-rated Sun Healthcare Group
SUNH as cost controls help the company meet quarterly consensus.
Jefferies comments, "SUNH missed top line expectations (due to a milder-than-expected flu season) but still met consensus EPS via impressive cost controls. SUNH appears on target to achieve its FY12 EPS outlook of $0.45-$0.60, but concerns about continued top line weakness might pressure
the stock near-term. Maintain Hold/$8PT (up from $5)."
SUNH closed at $7.00 on Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in